INTRODUCTION
The radioguided surgery technique has strongly evolved since its introduction in the early 1960's (1,2) whereby the sentinel node biopsy procedure can be considered the bestknow example. Basically this technique uses a radiotracer to (specifically) label lesions that require surgical removal. In case of sentinel node (SN) biopsy, following the injection of a radiocolloid (often 99m Tc-nanocolloid) in or around the primary tumor, upon drainage of the radiocolloid through the lymphatic system the primary tumor draining lymph node(s), so-called sentinel nodes (SNs) can be identified [3] . Acoustic (and numerical) feedback generated by a gamma-ray detection probe (GP) can then be used to provide directional guidance during the intervention [4] . Alternatively, portable gamma-imaging modalities can be used to provide an intraoperative image of the nodal uptake [5, 6] . Despite research oriented efforts commercially available portable gamma detection modalities do not yet allow depiction of detailed anatomical information [7, 8] .
To provide high resolution optical identification of the SNs, small dyes such as patent blue (V), fluorescein, and indocyanine green (ICG) have been used [9, 10] . Unfortunately, when radiocolloids and fluorescent agents are used separately, superficial intraoperative optical findings (<1 cm) can deviate from the (in-depth) observations made using the radiocolloid [11] . Such shortcomings can be overcome using a hybrid tracer, for example indocyanine green (ICG)- Tc-nanocolloid has already been extensively demonstrated by us [12] [13] [14] and others [11, 15] whereby it was shown that using the hybrid tracer allows for direct translation of (in-depth) preoperative imaging findings into the operation theatre. The radiolabel of the hybrid tracer allows preoperative SN mapping in a similar fashion as the conventional radioguided approach [12] , meaning it also provides directional information for the placement of the incisions. During the operation the combination of radio-and fluorescence guidance can be used to refine this even further by confirming the actual location and removal of the sentinel lymph nodes defined at preoperative imaging [12] [13] [14] . This combined approach significantly outperformed blue dye based sentinel node identification [12] [13] [14] .
The increase in the combined clinical use of radio-and fluorescence-guidance methodologies, either using separate radioactive and fluorescent tracers or by using hybrid tracers has generated a need for multiple detection modalities in the operating room. This in turn has driven the development of integrated (or rather hybrid) navigation set-ups wherein the Hybrid surgical guidance: Does hardware integration of gamma-and fluorescence-imaging modalities make sense? | 145 fluorescence camera is positioned using single photon emission computed tomography (SPECT)-based findings [16, 17] . To date only one true hybrid modality has been reported on in clinical use, namely a gamma-probe-based device that was extended with fiber based acoustic fluorescence tracing capabilities [18] . Based on this success one may wonder if it is also possible to accomplish the reverse in engineering by extending a known surgical fluorescence camera technology with the ability to detect gamma rays. To this end we combined a small-sized fluorescence camera (VITOM) [19, 20] with a gamma probe (GP) and a portable gamma camera (GC). Using these two set-ups, we assessed the clinical logistics during the intervention and identified the engineering challenges that need to be resolved in order to make an optimal hybrid detection apparatus for clinical use.
METHODS

Hardware
Near infrared-fluorescence imaging was performed using a lightweight fluorescence camera A hand-held GP (Europrobe 2, Eurorad, Eckbolsheim, France), providing both a numeric and an acoustic read-out, was used for intraoperative gamma tracing. A mobile GC (Sentinella; Oncovision, Valencia, Spain) was used for intraoperative gamma imaging (21) . The latter is equipped with a hand-controlled laser pointer that enables marking of the focus point/ location of gamma imaging on the skin or in the wound.
Engineering of the clip-on devices
To connect the VITOM to the GP or GC, custom clip-on brackets were designed using threedimensional (3D) computer-aided engineering software (Solidworks; Dassault Systèmes, Vélizy-Villacoublay, France) and subsequently 3D printed (VDM Kunststoftechniek, Doetinchem, the Netherlands) in sterilizable RC31 (Envisiontec, Gladbeck, Germany) (Supplemental Figure 1) .
The clip-on brackets were engineered in such a way that the focal points of gamma detection devices and the fluorescence camera were aligned ( Figure 1 and Supplemental Figure 1 ). For the fluorescence camera and gamma probe combination (VITOM-GP), the focal point was ≈11 cm, with an angle in alignment of both detection modalities of 7.24° (Figure 2A ). For the fluorescence camera and gamma camera combination (VITOM-GC), the VITOM was placed under a 33.8° angle. The focal point was again localized at ≈11 cm (measured from the tip of the VITOM) and at 6.4 cm from the collimator of the GC (9.5 cm from the detector; Figure 1B ).
Patients
Eleven patients with cT1-cT3N0 penile cancer scheduled for SN biopsy and subsequent treatment of the primary tumor were prospectively included after obtaining written informed consent. Patient characteristics are shown in Table 1 . 
Injection procedure and preoperative imaging
Hybrid tracer injection and preoperative SN mapping were performed one day prior to surgery or on the morning of the day of surgery as previously described (13) . In brief, four deposits of 0.1 mL hybrid tracer ICG99m Tc-nanocolloid were injected per patient around the primary lesion. Dynamic (during the first ten minutes post injection) and static (at fifteen minutes and two hours post injection) planar lymphoscintigraphy was performed. Lymphoscintigrams at two hours post injection were followed by single photon emission computed tomography fused with computed tomography (SPECT/CT) imaging. The number and location of SNs was determined based on preoperative imaging and marked on the skin.
System evaluation
The current study was performed by experienced surgical personnel that regularly uses intraoperative fluorescence-and gamma tracing modalities, even in combination with the hybrid tracer [13] .
Prior to incision the ability of the VITOM-GP or the VITOM-GC to detect the SN transcutaneously, via fluorescence imaging [22] and gamma detection, was evaluated when the probe was placed in direct contact with the skin (0 cm; VITOM-GP only)) and at the optimal focal point (≈11 cm) of the VITOM. After tissue preparation and full exposition Hybrid surgical guidance: Does hardware integration of gamma-and fluorescence-imaging modalities make sense? | 147 of the SN, the sensitivity of fluorescence imaging and gamma detection (visual or acoustic (numeric)) of the VITOM-GP and VITOM-GC was evaluated at different working distances namely: 0 cm (VITOM-GP only), 10 cm (≈VITOM focal plane), 20 cm and 30 cm (Figure 2 ).
The efficiency of detection was scored and presented in percentage detected SNs relative to the total amount of SNs pursued ( Table 1 ). The true value of a possible future hybrid device was evaluated in the focal plane as here both signals were detected synchronically in the same focal spot.
After SN excision, the wound bed was checked for the presence of residual radioactivity and fluorescence with either the VITOM-GC or VITOM-GP. The SNs that were removed without evaluation of the respective hybrid modality were located with intermittent use of the GP and fluorescence detection (VITOM).
Pathology
Excised tissue specimens were processed as described previously [13] .
RESULTS
Preoperative imaging and pathology
Details on the injected dose of the hybrid tracer, preoperative SN mapping, as well as pathology results are stated in Table 1 .
Intraoperative evaluation of the VITOM-GP combination
Preoperatively fourteen SNs were identified on SPECT/CT in the VITOM-GP patient group. For practical reasons in some patients the limited available time prevented us to evaluate all SNs using the VITOM-GP combination. Therefor only nine of these fourteen preoperatively identified SNs were included in the evaluation of the VITOM-GP combination.
Prior to placement of the incision the gamma detection rate was 100% in all cases. In contrast, via fluorescence detection none of the SNs could be detected transcutaneously ( Figure 3C ). Here it should be noted that the VITOM was unable to fully focus at this short distance (0 cm). Upon SN exposure, the detection rates in the focal plane (≈11 cm from the SN) were 88.9% for the gamma detection and 100% for fluorescence detection. At 20 and 30 cm working distance, gamma tracing identified 55.6% of the pursued SNs, while fluorescence imaging enabled detection of 88.9% of the SNs (Figure 2) . At the larger distances SN detection using the numeric/acoustic nature of the read-out of the GP was sometimes hindered by emissions coming from the nearby primary injection site.
The VITOM-GP combination was relatively small in size and could easily be handled with one hand. It also allowed real-time interpretation of both the gamma signal (acoustic/numeric) and fluorescence signal (on-screen, visual). When moving the device, the gamma tracing option provided directional feedback for the placement of the VITOM-GP. As a result of the angulation of the different modalities, dual imaging was only possible at the focal point (≈11 cm). Beyond that distance placement of the two modalities had to be corrected horizontally to accommodate fluorescence detection (Figure 1 ).
Intraoperative evaluation of the VITOM-GC combination
Again, for practical reasons only ten of the fifteen SNs identified using SPECT/CT were surgically pursued with the VITOM-GC combination. Prior to initiation of the surgical procedure the detection rate of the GC was 100%, irrespective of the evaluated working distance (10, 20, or 30 cm). Transcutaneous fluorescence-based SN detection was not possible. Upon SN exposure, the GC detection rate remained 100%. Fluorescence imaging provided a 90% detection rate at the focal plane, which dropped to 80% at 20 and 30 cm.
When performing gamma imaging beyond 20 cm distance, the injection site also became visible. Other than with the GP (see above), here the GC signal could be used to aid in the orientation ( Figure 2J and 2K ).
The VITOM-GC combination was large and heavy, and required a retractable (external) supporting device for placement. This device was considered convenient as it enabled accurate camera placement for longer periods of time, while leaving the surgeons hands free to perform the resection under image guidance. The laser pointer on the GC could be used to highlight the area of interest during gamma imaging (acquisition times up to 30 sec). However, as the pointer interfered with the fluorescence findings, it had to be switched off before fluorescence imaging was initiated (Supplemental Figure 2E and 2F ).
Data interpretation in the focal plane was limited by the fact that both signals were visually displayed and the operating surgeon had to look at two screens to determine the relation between the two findings. Beyond the focal point the large angle between both modalities (33.8°) meant that the spatial displacement between fluorescence-and gamma imaging findings was even more critical in this set-up.
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Figure 1. Schematic overview of the VITOM-GP and VITOM-GC combination.
A: The VITOM-GP combination.
B:
The VITOM-GC combination. Because of the angle in alignment the devices had to be moved horizontally, to compensate for misalignment at distances beyond the focal plane. 
DISCUSSION
This study describes two hybrid imaging set-ups (VITOM-GP and VITOM-GC) and their potential to provide surgical guidance in combination with the hybrid tracer ICG99m Tcnanocolloid. In both set-ups the in-depth information of the gamma signal was used to determine the site of incision and provided directional guidance for positioning of the VITOM. When the SN was exposed fluorescence imaging could be used to visually detect the SNs with respect to the anatomical context. These findings clearly underline the strengths and weaknesses of the two individual imaging signatures. Moreover, the reported detection percentages show that the hybrid modality-based find rates are highly similar to those previously reported for the individual modalities [13] . The current prototype set-up was not optimized from an efficacy point of view and their use influenced operating room logistics and the operation time. Nevertheless, in future studies, it remains to be evaluated it the use of an optimized hybrid modality can result in reduced morbidity, operation time and postoperative infection rates.
From the findings of the current study we were able to derive a number of engineering challenges that have to be faced before imaging-based hybrid surgical guidance modalities will become efficient tools for routine use. The clip-on design was considered convenient as it efficiently combined two clinically available modalities, but still allowed for their individual use. Unfortunately, the angled alignment was not optimal for distances smaller or larger than the focal plane. In both combined devices the angle between the modalities dictated spatial placement in order to get the information from the SN for both modalities (Figure 1 ).
Most likely future hybrid modalities will require both modalities to be placed perpendicular to each other and with an identical field of view. Though this will require full hardware integration. The findings of the current study also suggest that placement of both image guidance modalities on a stable, but retractable, arm could be of value.
In the current set up the optimal detection plane of the individual modalities was shown to differ for the VITOM (>11 cm), GP (0-10 cm) and GC (0-30 cm). Furthermore, intraoperative adaptation of the fluorescence focus was considered inconvenient. The concept of hybrid imaging hardware could only be accurately evaluated in the focal plane of the VITOM (≈11 cm). In future hybrid devices the focus of the two modalities should be matched, at least in a certain range. Possibly an autofocus option should also be included for the optical imaging.
The difference in fluorescence detection between the VITOM-GP and VITOM-GP could partly be explained by the failure of fluorescence detection in a patient with a body mass index over 40. Fatty tissue hampers the fluorescence signal detection and this risk increases in patients with obesity.
The largest and final hurdle to be tackled, however, will be the difference in detection sensitivity between the radioguidance and fluorescence modalities used. Although full integration is possible from an engineering point of view, its realization is not straightforward when combination of state-of-the art detector sensitivity for both fluorescence and radioactivity is envisioned. Especially when considering that the fluorescence modality could benefit from higher fluorescence sensitivity at longer distances. This would require both a stronger excitation light-source and higher detection sensitivity. The white light option should remain included as this information created directional feedback and provided anatomical context.
The difference in sensitivity between the GP and GC modalities influenced the acquisition time, collimation and field of view [2, 6] , all of which can be improved further.
Overall the VITOM-GP combination was preferred by the surgeons over the VITOM-GC combination. The reason for this was that the acoustic/numerical feedback provided by the GP provided information that could be processed simultaneously with the fluorescence imaging findings. Hereby two sensory organs, ears and eyes, work in conjunction, providing directional guidance for the placement of the fluorescence camera. In contrast, parallel display of the VITOM and GC findings relied on a single sensory organ, making it more difficult to process. Having the display of the two different imaging findings on two different screens was sometimes considered confusing. Hereby especially the lack of anatomical information in the GC images made it difficult to relate them to the fluorescence imaging findings. The value of the VITOM-GC combination could potentially increase when both imaging findings are integrated in a single (video screen) display, a technology that we previously successfully applied in a navigation set-up [23] .
CONCLUSION
In this study we demonstrated that combined radio-and fluorescence imaging modalities have the potential to make sense in the hybrid surgical guidance concept. The integrated detection modalities were shown to work synergistically; overall the GC was most valuable for rough localization (10-30cm range) of the SNs, the GP for providing convenient real-time acoustic feedback, while fluorescence guidance allowed detailed real-time SN visualization.
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